But it first needs a regulatory green light. 💉 engineering
. According to the report, the two-dose regimen followed for other adults would also be used for children, once authorized.
As the number of cases due to the Omicron is way beyond its peak in the U.S. data, the focus is likely to shift back to strengthening immunities of individuals using booster vaccines. Pfizer has already specifically against the Omicron variant but while data on that will take time to arrive, authorities are keen to vaccinate the children under five years of age in the country and have urged the company to submit its data for necessary approvals.
According to the WP report, Pfizer and BioNTech have also been gathering data on whether a third dose provides better protection than the two-dose regimen. However, the data is expected to be available only in late March and authorities do not want to wait that long to make decisions on vaccinating children under five years of age.
Sources told WP that authorities can begin analyzing that the company will submit for the age group of six months to five years for the two-dose regimen and if they are satisfied with the numbers, could approve the vaccination for the age group before the month could end. The decision on whether to make a third dose part of vaccination against COVID-19 could be made later when more data would be available.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
GOP-Led States Take Aim at Covid-19 Vaccine Mandates for School ChildrenFourteen states have measures pending to ban or limit Covid-19 vaccine mandates for school children, and recent polling finds a majority of U.S. parents opposed to mandates
Lire la suite »
Nurses Accused Of Selling Forged COVID-19 Vaccine Cards In $1.5 Million SchemeJulie DeVuono and Marissa Urrao allegedly sold vaccination cards that were obtained through DeVuono's health care practice in Long Island.
Lire la suite »
For many COVID-19 vaccine opponents, no jab means no jobTens of millions of Americans remain unvaccinated against COVID-19. For many, their stance on the vaccine may cost them their paychecks. Read more from jaweedkaleem and kurtisalee at
Lire la suite »
Moderna's COVID-19 vaccine gets full FDA approvalModerna's COVID-19 vaccine called “Spikevax” has been given full approval from the U.S. Food and Drug Administration.
Lire la suite »
Moderna COVID-19 vaccine gets full FDA approvalThe Moderna Covid-19 vaccine received full approval from the U.S. Food and Drug administration Monday, 11 months after the shot was given an emergency use authorization.
Lire la suite »